BYD Company Limited
002594
Contemporary Amperex Technology
300750
Kweichow Moutai
600519
4
Orient Group Incorporation
600811
5
Verisilicon Microelectronics (Shanghai) Co., Ltd.
688521
CN Stock MarketDetailed Quotes
000739 Apeloa Pharmaceutical
- 17.29
- -0.24-1.37%
Trading Mar 5 14:29 CST
20.22BMarket Cap18.83P/E (TTM)
17.66High17.21Low97.64KlotVolume17.48Open17.53Pre Close169.81MTurnover0.84%Turnover Ratio19.15P/E (Static)1.17BShares18.9652wk High3.07P/B20.21BFloat Cap11.9252wk Low19.28Limit Up1.17BShs Float40.98Historical High15.78Limit Down2.57%Amplitude-1.06Historical Low0.32Dividend TTM17.39Avg Price52.01KlotAsk1.83%Div YieldTTM100Lot Size43.88KlotBid
Apeloa Pharmaceutical News
Prologis Pharmaceuticals: Progress Announcement on the Repurchase of the Company\'s Shares
Prologis Pharmaceuticals: Report on share repurchase
Prologis Pharmaceutical: Announcement on the shareholding status of the top ten shareholders and the top ten shareholders with unlimited sales conditions for share repurchases
Prologis Pharmaceuticals: Announcement on the plan to repurchase the company\'s shares
Prologis Pharmaceutical: Announcement on the expiration of the share repurchase period and the implementation results of the repurchase
Prologis Pharmaceuticals: Progress Announcement on the Repurchase of the Company\'s Shares
Apeloa Pharmaceutical: Announcement regarding the progress of repurchasing company shares.
Apeloa Pharmaceutical: Announcement regarding the progress of repurchasing company shares.
Apeloa Pharmaceutical: Announcement on the completion of share repurchase cancellation and changes in shareholding
Apeloa Pharmaceutical: Announcement regarding the progress of repurchasing company shares.
Apeloa Pharmaceutical: 2023 dividend payment implementation announcement
Apeloa Pharmaceutical: Announcement on the progress of the repurchase of company shares
Prologis Pharmaceuticals: Announcement on the initial repurchase of the company's shares
Prologis Pharmaceutical: Announcement on the shareholding status of the top ten shareholders and the top ten shareholders with unlimited sales conditions for share repurchases
Prologis Pharmaceuticals: Report on share repurchase
Prologis Pharmaceutical: Announcement on the pledge of part of the company's controlling shareholder
Prologis Pharmaceuticals: Announcement on the plan to repurchase the company's shares
Prologis Pharmaceutical: Announcement on the cancellation of the company's controlling shareholder's share pledge
Prologis Pharmaceuticals: Announcement on the 2023 Profit Distribution Plan
Prologis Pharmaceuticals: Progress Announcement on the Continued Separation of Shareholders and Changes in Equity of 5% or More